Literature DB >> 12739810

Nosocomial sources of cryptosporidial infection in newly admitted patients in Ain Shams University Pediatric Hospital.

Mohmoud M el-Sibaei1, Manal M A Rifaat, Dina M Abdel Hameed, Hayam M Ezz el-Din.   

Abstract

Cryptosporidium parvum has a world wide distribution. Numerous nosocomial outbreaks of cryptosporidiosis have occurred, also numerous well documented water born outbreaks have occurred. The present study included 104 patients and 27 contacts, both were subjected to stool examination by MZN stain. ELISA for detection of Cryptosporidium Ag in stool was further carried out for the patients developing diarrhea after admission (12), patients admitted with diarrhea (17), and for contacts. Twenty four water samples collected from Pediatric Hospital, and examined by MZN and ELISA. The results showed that 11.5% of examined cases developed diarrhea after admission. 8% of them were positive for cryptosporidiosis by both MZN and ELISA. 17% (3/27) of the contacts were negative by MZN stain. ELISA was found to be 100% sensitive, 94.1% specific. Water samples were found to be negative for C. parvum.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12739810

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  3 in total

Review 1.  Cryptosporidium and cryptosporidiosis: the African perspective.

Authors:  Hebatalla M Aldeyarbi; Nadia M T Abu El-Ezz; Panagiotis Karanis
Journal:  Environ Sci Pollut Res Int       Date:  2016-04-29       Impact factor: 4.223

2.  Extended outbreak of cryptosporidiosis in a pediatric hospital, China.

Authors:  Yaoyu Feng; Lin Wang; Liping Duan; Luis A Gomez-Puerta; Longxian Zhang; Xukun Zhao; Jingjing Hu; Nan Zhang; Lihua Xiao
Journal:  Emerg Infect Dis       Date:  2012-02       Impact factor: 6.883

3.  Prevalence of Parasitic Infections in Surgically Removed Appendices: Parasitological and Histopathological Studies.

Authors:  A S Amer; A E Saad; S N Antonios; E A Hasby
Journal:  Helminthologia       Date:  2018-01-27       Impact factor: 1.184

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.